Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2

BACKGROUND: Cardiovascular complications have been increasingly recognized in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated coronavirus disease 2019 (COVID-19). Cardiac biomarkers are released because of this ongoing cardiovascular injury and can act as surrogate marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthyala, Anjani, Sasidharan, Sandeep, John, Kevin John, Lal, Amos, Mishra, Ajay K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523328/
https://www.ncbi.nlm.nih.gov/pubmed/36188743
http://dx.doi.org/10.5501/wjv.v11.i5.375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523328/
https://www.ncbi.nlm.nih.gov/pubmed/36188743
http://dx.doi.org/10.5501/wjv.v11.i5.375

Ejemplares similares